N-acetylglucosamine - An osmotic solute for peritoneal dialysis without inducing hyperinsulinemia

Blood Purification

Volumn 22, Issue 2, 2004, Pages 183-187

  Breborowicz A ^a   Polubinska A ^a   Simon, M ^a   Tam, P ^b   Wu, G ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b SRI Partnership   (Canada)

Author keywords

Glucose; Insulin; N Acetylglucosamine; Peritoneal dialysis

Indexed keywords

GLUCOSE; INSULIN; N ACETYLGLUCOSAMINE; OSMOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIALYSATE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PERITONEAL DIALYSIS; PERMEABILITY; PRIORITY JOURNAL; RAT; TRANSPORT KINETICS;

ACETYLGLUCOSAMINE; ADSORPTION; ANIMALS; BLOOD GLUCOSE; DIALYSIS SOLUTIONS; GLUCOSE; GLYCEROL; HYPERINSULINISM; INSULIN; MALE; OSMOSIS; PERITONEAL DIALYSIS; RATS; RATS, WISTAR; WATER;

EID: 1842559325     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076851     Document Type: Article

References (25)

1. Khanna R: Peritoneal dialysis in diabetic endstage renal disease; in Gokal R, Nolph KD (eds): The Textbook of Peritoneal Dialysis. Dordrecht, Kluwer Academic, 1994, pp 639-659.
2. Heaton A, Ward MK, Johnston DG, Nicholson DV, Alberti KG, Kerr DN: Short-term studies on the use of glycerol as an osmotic agent in continuous ambulatory peritoneal dialysis. Clin Sci 1984;67:121-130.
3. Brȩborowicz A, Rodela H, Oreopoulos DG: Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 1992;41:1280-1285.
4. Lameire N, Faict D: Peritoneal dialysis solutions containing glycerol and amino acids. Perit Dial Int 1994;14(suppl 3):S145-S151.
5. Matthys E, Dolkart R, Lameire N: Potential hazards of glycerol dialysate in diabetic CAPD patients. Perit Dial Bull 1987;7:16-19.
6. Rippe B, Zakaria ER, Carlsson O: Theoretical analysis of osmotic agents in peritoneal dialysis. What size is an ideal osmotic agent? Perit Dial Int 1996;16(suppl 1):S97-S103.
7. Mistry CD, Mallick NP, Gokal R: Ultrafiltration with isosmotic solution during long peritoneal exchanges. Lancet 1987;ii:178-182.
8. Queffeulou G, Bernard M, Vrtovsnik F, Skhiri H, Lebrun-Vigne B: Severe cutaneous hypersensitivity requiring permanent icodextrin withdrawal in a CAPD patient. Clin Nephrol 1999;51:184-186
9. Goldsmith D, Jayawardene S, Sabharwal N, Cooney K: Allergic reactions to the polymeric glucose-based peritoneal dialysis fluid icodextrin in patients with renal failure. Lancet 2000;355:897.
10. Brȩborowicz A, Kużlan-Pawlaczyk M, Wieczorowska-Tobis K, Wiśniewska J, Tam P, French I, Wu G: The effect of N-acetylglucosamine as a substrate for in vitro synthesis of glycosaminoglycans by human peritoneal mesothelial cells and fibroblasts. Adv Perit Dial 1998;14:31-35.
11. Brȩborowicz A, Połubinska A, Moberly J, Ogle K, Martis L, Oreopoulos DG: Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats. Am J Kidney Dis 2001;37:594-600.
12. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
13. Kużlan M, Pawlaczyk K, Wieczorowska-Tobis K, Korybalska K, Brȩborowicz A, Oreopoulos DG: Peritoneal surface area and its permeability in rats. Perit Dial Int 1997;17:295-300.
14. Brȩborowicz A, Wieczorowska-Tobis K, Kuzlan M, et al: N-Acetylglucosamine: A new osmotic solute in peritoneal dialysis solutions. Perit Dial Int 1997;17(suppl 2):S80-S83.
15. Brȩborowicz A, Wiśniewska J, Polubinska A, Wieczorowska-Tobis K, Martis L, Oreopoulos DG: Role of peritoneal mesothelial cells and fibroblasts in synthesis of hyaluronan during peritoneal dialysis. Perit Dial Int 1998;18:382-386.
16. Wu G, Wieczorowska-Tobis K, Polubinska A, Korybalska K, Filas V, Tam P, French I, Brȩborowicz A: N-Acetylglucosamine changes permeability of peritoneum during chronic peritoneal dialysis in rats. Perit Dial Int 1998;18:217-224.
17. Połubinska A, Pawlaczyk K, Kużlan-Pawlaczyk M, et al: Dialysis solution containing hyaluronan: Effect on peritoneal permeability and inflammation in rats. Kidney Int 2000;57:1182-1189.
18. Rosengren BI, Carlsson O, Rippe B: Hyaluronan and peritoneal ultrafiltration: A test for the 'filter-cake' hypothesis. Am J Kidney Dis 2001;37:1277-1285.
19. Lindholm B, Bergstrom J: Nutritional requirements of peritoneal dialysis patients; in Gokal R, Nolph KD (eds): The Textbook of Peritoneal Dialysis. Dordrecht, Kluwer Academic, 1994, pp 443-472.
20. Prichard S: Major and minor risk factors for cardiovascular disease in peritoneal dialysis. Perit Dial Int 2000;20(suppl 2):S154-S159.
21. Ashcroft SJH, Ceossley JR: The effects of glucose, N-acetylglucosamine, glyceraldehydes and other sugars on insulin release in vivo. Diabetologia 1975;11:279-284.
22. Zawalich WS, Dye ES, Matschinsky FM: Metabolism and insulin releasing capabilities of glucosamine and N-acetylglucosamine in isolated rat islets. Biochem J 1979;180:145-152.
23. Lenzen S: Insulin secretion by isolated perfused rat and mouse pancreas. Am J Physiol 1979;236:E391-E400.
24. Kohn P, Winzler RJ, Hoffman RC: Metabolism of D-glucosamine and N-acetyl-D-glucosamine in the intact rat. J Biol Chem 1962;237:304-308.
25. Gaulden EC, Keating WC: The effect of intravenous N-acetyl-D-glucosamine on the blood and urine sugar concentrations of normal subjects. Metabolism 1964;13:466-472.